176 related articles for article (PubMed ID: 34031132)
41. [The antibody spectrum after the inoculation of sensitive animals with Yersinia pestis and Yersinia pseudotuberculosis bacteria].
Drobkov VI; Marakulin IV; Pogorel'skiĭ IP; Darmov IV; Smirnov EV
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):81-5. PubMed ID: 8701667
[TBL] [Abstract][Full Text] [Related]
42. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
Lukacher AE; Moser JM; Hadley A; Altman JD
J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
[TBL] [Abstract][Full Text] [Related]
43. The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.
Chung LK; Park YH; Zheng Y; Brodsky IE; Hearing P; Kastner DL; Chae JJ; Bliska JB
Cell Host Microbe; 2016 Sep; 20(3):296-306. PubMed ID: 27569559
[TBL] [Abstract][Full Text] [Related]
44. "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming.
Rüssmann H; Panthel K
Int J Med Microbiol; 2004 Oct; 294(5):313-7. PubMed ID: 15532990
[TBL] [Abstract][Full Text] [Related]
45. γδ T cell IFNγ production is directly subverted by Yersinia pseudotuberculosis outer protein YopJ in mice and humans.
Chu TH; Khairallah C; Shieh J; Cho R; Qiu Z; Zhang Y; Eskiocak O; Thanassi DG; Kaplan MH; Beyaz S; Yang VW; Bliska JB; Sheridan BS
PLoS Pathog; 2021 Dec; 17(12):e1010103. PubMed ID: 34871329
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.
Falgarone G; Blanchard HS; Riot B; Simonet M; Breban M
Infect Immun; 1999 Aug; 67(8):3773-9. PubMed ID: 10417137
[TBL] [Abstract][Full Text] [Related]
47. Expression of intracellular IFN-gamma in HSV-1-specific CD8+ T cells identifies distinct responding subpopulations during the primary response to infection.
Andersen H; Dempsey D; Chervenak R; Jennings SR
J Immunol; 2000 Aug; 165(4):2101-7. PubMed ID: 10925295
[TBL] [Abstract][Full Text] [Related]
48. Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague.
Lin JS; Szaba FM; Kummer LW; Chromy BA; Smiley ST
J Immunol; 2011 Jul; 187(2):897-904. PubMed ID: 21653834
[TBL] [Abstract][Full Text] [Related]
49. Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection.
Rutigliano JA; Ruckwardt TJ; Martin JE; Graham BS
Virology; 2007 Jun; 362(2):314-9. PubMed ID: 17275872
[TBL] [Abstract][Full Text] [Related]
50. Delayed expansion and contraction of CD8+ T cell response during infection with virulent Salmonella typhimurium.
Luu RA; Gurnani K; Dudani R; Kammara R; van Faassen H; Sirard JC; Krishnan L; Sad S
J Immunol; 2006 Aug; 177(3):1516-25. PubMed ID: 16849458
[TBL] [Abstract][Full Text] [Related]
51. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
[TBL] [Abstract][Full Text] [Related]
52. Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine.
Barnes PD; Bergman MA; Mecsas J; Isberg RR
J Exp Med; 2006 Jun; 203(6):1591-601. PubMed ID: 16754724
[TBL] [Abstract][Full Text] [Related]
53. Regulation of CD8+ T cells undergoing primary and secondary responses to infection in the same host.
Badovinac VP; Messingham KA; Hamilton SE; Harty JT
J Immunol; 2003 May; 170(10):4933-42. PubMed ID: 12734336
[TBL] [Abstract][Full Text] [Related]
54. Development of memory CD8+ T cells and their recall responses during blood-stage infection with Plasmodium berghei ANKA.
Miyakoda M; Kimura D; Honma K; Kimura K; Yuda M; Yui K
J Immunol; 2012 Nov; 189(9):4396-404. PubMed ID: 23008449
[TBL] [Abstract][Full Text] [Related]
55. [Biologically active Yersinia pseudotuberculosis biopolymers].
Dzadzieva MF
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):33-7. PubMed ID: 9432843
[No Abstract] [Full Text] [Related]
56. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response.
Falgarone G; Blanchard HS; Virecoulon F; Simonet M; Breban M
J Immunol; 1999 Mar; 162(5):2875-83. PubMed ID: 10072536
[TBL] [Abstract][Full Text] [Related]
57. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
[TBL] [Abstract][Full Text] [Related]
58. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection.
Pope C; Kim SK; Marzo A; Masopust D; Williams K; Jiang J; Shen H; Lefrançois L
J Immunol; 2001 Mar; 166(5):3402-9. PubMed ID: 11207297
[TBL] [Abstract][Full Text] [Related]
59. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
[TBL] [Abstract][Full Text] [Related]
60. Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.
Porte R; Van Maele L; Muñoz-Wolf N; Foligné B; Dumoutier L; Tabareau J; Cayet D; Gosset P; Jonckheere N; Van Seuningen I; Chabalgoity JA; Simonet M; Lamkanfi M; Renauld JC; Sirard JC; Carnoy C
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27872237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
